Flagship Dialogues @ JPM: When Biotech Gets Personal with Michelle C. Werner & David Fajgenbaum
Flagship Dialogues @ JPM: A conversation between two leaders in our industry whose work is intensely personal. David Fajgenbaum, MD, was diagnosed with a rare disease – Castleman Disease – while in medical school and, through persistence and ingenuity found treatment where none had been available. He sat down with Flagship Pioneering CEO-Partner and CEO of Alltrna Michelle C. Werner who has similarly personal motivations for finding gene-modifying therapies for rare genetic diseases. About Flagship: Flagship Pioneering is a biotechnology company that invents and builds platform companies, eac…
